John Lazarchick to Biomarkers
This is a "connection" page, showing publications John Lazarchick has written about Biomarkers.
Connection Strength
0.142
-
Characterization of Mast Cell Activation Syndrome. Am J Med Sci. 2017 03; 353(3):207-215.
Score: 0.098
-
D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA? PLoS One. 2017; 12(1):e0169268.
Score: 0.025
-
Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis. Am J Hematol. 2013 Nov; 88(11):E265-72.
Score: 0.019